HCA
RGNX icon

Harbor Capital Advisors’s Regenxbio RGNX Stock Holding History

Harbor Capital Advisors’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$406K Sell
33,929
-14,563
-30% -$121K 0.03% 555
2026
Q1 		$406K Buy
+48,492
New +$509K 0.03% 516
2025
Q1 		– Sell
-25,607
Closed -$198K – 1515
2024
Q4 		$198K Sell
25,607
-10,475
-29% -$98.4K 0.01% 660
2024
Q3 		$379K Buy
36,082
+11,784
+48% +$144K 0.02% 608
2024
Q2 		$284K Sell
24,298
-30,303
-55% -$472K 0.02% 616
2024
Q1 		$1.15M Buy
54,601
+5,052
+10% +$89.9K 0.15% 179
2023
Q4 		$889K Buy
49,549
+990
+2% +$17.4K 0.17% 152
2023
Q3 		$799K Buy
48,559
+4,453
+10% +$80.7K 0.17% 148
2023
Q2 		$882K Buy
44,106
+19,830
+82% +$382K 0.18% 150
2023
Q1 		$459K Sell
24,276
-2,409
-9% -$53.3K 0.13% 149
2022
Q4 		$605K Sell
26,685
-574
-2% -$13K 0.59% 57
2022
Q3 		$720K Sell
27,259
-2,992
-10% -$88.8K 0.66% 50
2022
Q2 		$747K Sell
30,251
-2,209
-7% -$55.2K 0.57% 57
2022
Q1 		$1.08M Sell
32,460
-5,793
-15% -$161K 0.51% 59
2021
Q4 		$1.25M Buy
+38,253
New +$1.3M 0.46% 63

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Harbor Capital Advisors's RGNX Position: Q2 2026 in Review

Harbor Capital Advisors reduced its Regenxbio (RGNX) stake by 30% in Q2 2026, selling an estimated $121K and leaving 33,929 shares worth $406K. The position accounts for 0.03% of the portfolio, ranked #555.

Harbor Capital Advisors first reported a position in RGNX in Q4 2021 and has held it in 15 quarters since. The position peaked at $1.25M in Q4 2021. 165 funds tracked by Wall St. Rank hold RGNX as of Q2 2026.

  • Harbor Capital Advisors held 33,929 shares of Regenxbio worth $406K as of Q2 2026.
  • Harbor Capital Advisors sold 14,563 Regenxbio shares in Q2 2026, an estimated $121K.
  • Regenxbio made up 0.03% of Harbor Capital Advisors's portfolio in Q2 2026, its #555 holding.
  • Harbor Capital Advisors first reported a position in Regenxbio in Q4 2021 and has held it in 15 quarters since.
  • Harbor Capital Advisors's Regenxbio position peaked at $1.25M in Q4 2021.
  • 165 funds tracked by Wall St. Rank held Regenxbio as of Q2 2026.

Based on Harbor Capital Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.